XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$2.65
-0.11 (-3.99%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,509.1% upside
Low Target
$28.32
Average Target
$42.64
High Target
$47.79
Current Price
$2.65
Current
$2.65
$2.65
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Scenario Analysis
Bear Case
$28.32
968.7%
Low target
Base Case
$42.64
+1,509.1%
Avg target
Bull Case
$47.79
+1,703.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.85
-73.1% from high
52-Week Low
$2.42
+9.5% from low
Target vs 52W High
$42.64
+332.9% vs high
Peer Consensus — Pharmaceuticals